- Home
- SNSE vs IMNN Comparison
SNSE vs IMNN Comparison
Compare SNSE & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- IMNN
- Stock Information
- Founded
- SNSE 2005
- IMNN 1982
- Country
- SNSE United States
- IMNN United States
- Employees
- SNSE N/A
- IMNN N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- SNSE Health Care
- IMNN Health Care
- Exchange
- SNSE Nasdaq
- IMNN Nasdaq
- Market Cap
- SNSE 12.5M
- IMNN 13.6M
- IPO Year
- SNSE 2021
- IMNN 1985
- Fundamental
- Price
- SNSE $0.45
- IMNN $0.92
- Analyst Decision
- SNSE Strong Buy
- IMNN Strong Buy
- Analyst Count
- SNSE 3
- IMNN 2
- Target Price
- SNSE $4.33
- IMNN $20.50
- AVG Volume (30 Days)
- SNSE 168.7K
- IMNN 147.2K
- Earning Date
- SNSE 03-03-2025
- IMNN 02-27-2025
- Dividend Yield
- SNSE N/A
- IMNN N/A
- EPS Growth
- SNSE N/A
- IMNN N/A
- EPS
- SNSE N/A
- IMNN N/A
- Revenue
- SNSE N/A
- IMNN N/A
- Revenue This Year
- SNSE N/A
- IMNN N/A
- Revenue Next Year
- SNSE N/A
- IMNN N/A
- P/E Ratio
- SNSE N/A
- IMNN N/A
- Revenue Growth
- SNSE N/A
- IMNN N/A
- 52 Week Low
- SNSE $0.38
- IMNN $0.56
- 52 Week High
- SNSE $1.94
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- SNSE 38.52
- IMNN 53.96
- Support Level
- SNSE $0.44
- IMNN $0.81
- Resistance Level
- SNSE $0.49
- IMNN $0.93
- Average True Range (ATR)
- SNSE 0.04
- IMNN 0.05
- MACD
- SNSE -0.00
- IMNN -0.00
- Stochastic Oscillator
- SNSE 10.73
- IMNN 68.13
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.